BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9013725)

  • 1. Subcellular localization and expression pattern of the neurofibromatosis type 2 protein merlin/schwannomin.
    Schmucker B; Ballhausen WG; Kressel M
    Eur J Cell Biol; 1997 Jan; 72(1):46-53. PubMed ID: 9013725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The merlin tumor suppressor localizes preferentially in membrane ruffles.
    Gonzalez-Agosti C; Xu L; Pinney D; Beauchamp R; Hobbs W; Gusella J; Ramesh V
    Oncogene; 1996 Sep; 13(6):1239-47. PubMed ID: 8808698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin.
    Shaw RJ; McClatchey AI; Jacks T
    Cell Growth Differ; 1998 Apr; 9(4):287-96. PubMed ID: 9563848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of molecular domains of epitope-tagged merlin isoforms in Cos-7 cells and primary rat Schwann cells.
    Xu L; Gonzalez-Agosti C; Beauchamp R; Pinney D; Sterner C; Ramesh V
    Exp Cell Res; 1998 Jan; 238(1):231-40. PubMed ID: 9457076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression level, subcellular distribution and rho-GDI binding affinity of merlin in comparison with Ezrin/Radixin/Moesin proteins.
    Maeda M; Matsui T; Imamura M; Tsukita S; Tsukita S
    Oncogene; 1999 Aug; 18(34):4788-97. PubMed ID: 10490812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of cellular proteins that interact with the NF2 tumor suppressor gene product.
    Takeshima H; Izawa I; Lee PS; Safdar N; Levin VA; Saya H
    Oncogene; 1994 Aug; 9(8):2135-44. PubMed ID: 8035998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurofibromatosis type 2 (NF2)].
    Araki N; Takeshima H; Saya H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Merlin, the neurofibromatosis type 2 gene product, and beta1 integrin associate in isolated and differentiating Schwann cells.
    Obremski VJ; Hall AM; Fernandez-Valle C
    J Neurobiol; 1998 Dec; 37(4):487-501. PubMed ID: 9858254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin.
    Scoles DR; Huynh DP; Morcos PA; Coulsell ER; Robinson NG; Tamanoi F; Pulst SM
    Nat Genet; 1998 Apr; 18(4):354-9. PubMed ID: 9537418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of NF2-encoded merlin and related ERM family proteins in the human central nervous system.
    Stemmer-Rachamimov AO; Gonzalez-Agosti C; Xu L; Burwick JA; Beauchamp R; Pinney D; Louis DN; Ramesh V
    J Neuropathol Exp Neurol; 1997 Jun; 56(6):735-42. PubMed ID: 9184664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system.
    Grönholm M; Teesalu T; Tyynelä J; Piltti K; Böhling T; Wartiovaara K; Vaheri A; Carpén O
    Mol Cell Neurosci; 2005 Apr; 28(4):683-93. PubMed ID: 15797715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2.
    Wiederhold T; Lee MF; James M; Neujahr R; Smith N; Murthy A; Hartwig J; Gusella JF; Ramesh V
    Oncogene; 2004 Nov; 23(54):8815-25. PubMed ID: 15467741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Layilin, a cell surface hyaluronan receptor, interacts with merlin and radixin.
    Bono P; Cordero E; Johnson K; Borowsky M; Ramesh V; Jacks T; Hynes RO
    Exp Cell Res; 2005 Aug; 308(1):177-87. PubMed ID: 15913605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton.
    den Bakker MA; Tascilar M; Riegman PH; Hekman AC; Boersma W; Janssen PJ; de Jong TA; Hendriks W; van der Kwast TH; Zwarthoff EC
    Am J Pathol; 1995 Nov; 147(5):1339-49. PubMed ID: 7485397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shedding light on Merlin's wizardry.
    Okada T; You L; Giancotti FG
    Trends Cell Biol; 2007 May; 17(5):222-9. PubMed ID: 17442573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
    Sherman L; Xu HM; Geist RT; Saporito-Irwin S; Howells N; Ponta H; Herrlich P; Gutmann DH
    Oncogene; 1997 Nov; 15(20):2505-9. PubMed ID: 9395247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells.
    Huynh DP; Pulst SM
    Oncogene; 1996 Jul; 13(1):73-84. PubMed ID: 8700556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumour suppressor protein NF2/merlin: the puzzle continues.
    Hovens CM; Kaye AH
    J Clin Neurosci; 2001 Jan; 8(1):4-7. PubMed ID: 11148074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromatosis 2 tumor suppressor, the gene induced by valproic acid, mediates neurite outgrowth through interaction with paxillin.
    Yamauchi J; Miyamoto Y; Kusakawa S; Torii T; Mizutani R; Sanbe A; Nakajima H; Kiyokawa N; Tanoue A
    Exp Cell Res; 2008 Jul; 314(11-12):2279-88. PubMed ID: 18486129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Merlin differentially associates with the microtubule and actin cytoskeleton.
    Xu HM; Gutmann DH
    J Neurosci Res; 1998 Feb; 51(3):403-15. PubMed ID: 9486775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.